General Information of Drug Off-Target (DOT) (ID: OTMHTPMZ)

DOT Name Uncharacterized protein C14orf93 (C14ORF93)
Gene Name C14ORF93
Related Disease
Thyroid tumor ( )
Thyroid cancer ( )
Thyroid gland carcinoma ( )
UniProt ID
CN093_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF15394
Sequence
MSFSATILFSPPSGSEARCCCCACKSETNGGNTGSQGGNPPPSTPITVTGHGLAVQSSEQ
LLHVIYQRVDKAVGLAEAALGLARANNELLKRLQEEVGDLRQGKVSIPDEDGESRAHSSP
PEEPGPLKESPGEAFKALSAVEEECDSVGSGVQVVIEELRQLGAASVGPGPLGFPATQRD
MRLPGCTLAASEAAPLLNPLVDDYVASEGAVQRVLVPAYAKQLSPATQLAIQRATPETGP
ENGTKLPPPRPEDMLNAAAALDSALEESGPGSTGELRHSLGLTVSPCRTRGSGQKNSRRK
RDLVLSKLVHNVHNHITNDKRFNGSESIKSSWNISVVKFLLEKLKQELVTSPHNYTDKEL
KGACVAYFLTKRREYRNSLNPFKGLKEKEEKKLRSRRYRLFANRSSIMRHFGPEDQRLWN
DVTEELMSDEEDSLNEPGVWVARPPRFRAQRLTELCYHLDANSKHGTKANRVYGPPSDRL
PSAEAQLLPPELYNPNFQEEEDEGGDENAPGSPSFDQPHKTCCPDLNSFIEIKVEKDE

Molecular Interaction Atlas (MIA) of This DOT

3 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Thyroid tumor DISLVKMD Definitive Biomarker [1]
Thyroid cancer DIS3VLDH Limited Biomarker [2]
Thyroid gland carcinoma DISMNGZ0 Limited Biomarker [2]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
6 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of Uncharacterized protein C14orf93 (C14ORF93). [3]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Uncharacterized protein C14orf93 (C14ORF93). [4]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Uncharacterized protein C14orf93 (C14ORF93). [5]
Cisplatin DMRHGI9 Approved Cisplatin increases the expression of Uncharacterized protein C14orf93 (C14ORF93). [6]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Uncharacterized protein C14orf93 (C14ORF93). [7]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of Uncharacterized protein C14orf93 (C14ORF93). [8]
------------------------------------------------------------------------------------
⏷ Show the Full List of 6 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Uncharacterized protein C14orf93 (C14ORF93). [9]
------------------------------------------------------------------------------------

References

1 Rtfc (4931414P19Rik) Regulates in vitro Thyroid Differentiation and in vivo Thyroid Function.Sci Rep. 2017 Feb 23;7:43396. doi: 10.1038/srep43396.
2 C14orf93 (RTFC) is identified as a novel susceptibility gene for familial nonmedullary thyroid cancer.Biochem Biophys Res Commun. 2017 Jan 22;482(4):590-596. doi: 10.1016/j.bbrc.2016.11.078. Epub 2016 Nov 15.
3 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
4 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
5 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
6 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
7 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
8 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.